nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCC3—Cisplatin—testicular cancer	0.0581	0.0774	CbGbCtD
Nifedipine—ABCC3—Etoposide—testicular cancer	0.0571	0.076	CbGbCtD
Nifedipine—CYP2A6—Ifosfamide—testicular cancer	0.053	0.0706	CbGbCtD
Nifedipine—ABCC3—Doxorubicin—testicular cancer	0.039	0.0519	CbGbCtD
Nifedipine—ABCC3—Methotrexate—testicular cancer	0.0377	0.0502	CbGbCtD
Nifedipine—CYP3A7—Ifosfamide—testicular cancer	0.0363	0.0483	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0363	0.0483	CbGbCtD
Nifedipine—CYP2B6—Ifosfamide—testicular cancer	0.0345	0.046	CbGbCtD
Nifedipine—ABCC2—Carboplatin—testicular cancer	0.0309	0.0411	CbGbCtD
Nifedipine—ABCC2—Vinblastine—testicular cancer	0.0288	0.0384	CbGbCtD
Nifedipine—CYP3A5—Ifosfamide—testicular cancer	0.0272	0.0362	CbGbCtD
Nifedipine—ABCC2—Cisplatin—testicular cancer	0.0264	0.0352	CbGbCtD
Nifedipine—CYP2C8—Ifosfamide—testicular cancer	0.0262	0.0348	CbGbCtD
Nifedipine—ABCC2—Etoposide—testicular cancer	0.026	0.0345	CbGbCtD
Nifedipine—CYP2C9—Ifosfamide—testicular cancer	0.0182	0.0243	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—testicular cancer	0.0177	0.0236	CbGbCtD
Nifedipine—ABCC2—Methotrexate—testicular cancer	0.0171	0.0228	CbGbCtD
Nifedipine—CYP2B6—Cisplatin—testicular cancer	0.0168	0.0224	CbGbCtD
Nifedipine—CYP2E1—Etoposide—testicular cancer	0.0167	0.0223	CbGbCtD
Nifedipine—ABCB1—Dactinomycin—testicular cancer	0.015	0.02	CbGbCtD
Nifedipine—CYP3A5—Etoposide—testicular cancer	0.013	0.0173	CbGbCtD
Nifedipine—CYP2C8—Etoposide—testicular cancer	0.0125	0.0166	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—testicular cancer	0.0113	0.015	CbGbCtD
Nifedipine—CYP3A4—Ifosfamide—testicular cancer	0.0106	0.0141	CbGbCtD
Nifedipine—CYP1A2—Etoposide—testicular cancer	0.00968	0.0129	CbGbCtD
Nifedipine—ABCB1—Vinblastine—testicular cancer	0.00939	0.0125	CbGbCtD
Nifedipine—CYP2C9—Cisplatin—testicular cancer	0.00887	0.0118	CbGbCtD
Nifedipine—CYP2D6—Vinblastine—testicular cancer	0.00885	0.0118	CbGbCtD
Nifedipine—ABCB1—Cisplatin—testicular cancer	0.00861	0.0115	CbGbCtD
Nifedipine—ABCB1—Etoposide—testicular cancer	0.00846	0.0113	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—testicular cancer	0.00577	0.00768	CbGbCtD
Nifedipine—CYP3A4—Vinblastine—testicular cancer	0.00563	0.00749	CbGbCtD
Nifedipine—ABCB1—Methotrexate—testicular cancer	0.00559	0.00744	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—testicular cancer	0.00544	0.00724	CbGbCtD
Nifedipine—CYP3A4—Etoposide—testicular cancer	0.00507	0.00675	CbGbCtD
Nifedipine—CALM2—semen—testicular cancer	0.00496	0.0998	CbGeAlD
Nifedipine—CALM1—semen—testicular cancer	0.00494	0.0994	CbGeAlD
Nifedipine—CYP3A4—Doxorubicin—testicular cancer	0.00346	0.0046	CbGbCtD
Nifedipine—CACNA1S—seminal vesicle—testicular cancer	0.0033	0.0664	CbGeAlD
Nifedipine—CACNA1H—seminal vesicle—testicular cancer	0.0021	0.0422	CbGeAlD
Nifedipine—CYP2A6—seminal vesicle—testicular cancer	0.00155	0.0313	CbGeAlD
Nifedipine—CACNA1H—gonad—testicular cancer	0.00152	0.0305	CbGeAlD
Nifedipine—CALM3—seminal vesicle—testicular cancer	0.00134	0.027	CbGeAlD
Nifedipine—CACNA1H—female gonad—testicular cancer	0.00123	0.0248	CbGeAlD
Nifedipine—CALM2—embryo—testicular cancer	0.00112	0.0225	CbGeAlD
Nifedipine—CALM1—embryo—testicular cancer	0.00111	0.0224	CbGeAlD
Nifedipine—CACNA1H—testis—testicular cancer	0.00109	0.022	CbGeAlD
Nifedipine—CACNA2D1—female gonad—testicular cancer	0.00109	0.022	CbGeAlD
Nifedipine—CALM2—seminal vesicle—testicular cancer	0.00105	0.0212	CbGeAlD
Nifedipine—CACNB2—testis—testicular cancer	0.00103	0.0208	CbGeAlD
Nifedipine—CACNA2D1—testis—testicular cancer	0.000969	0.0195	CbGeAlD
Nifedipine—CACNA1D—testis—testicular cancer	0.000902	0.0182	CbGeAlD
Nifedipine—ABCC3—female gonad—testicular cancer	0.000854	0.0172	CbGeAlD
Nifedipine—CACNA1C—testis—testicular cancer	0.000832	0.0168	CbGeAlD
Nifedipine—CACNA1H—lymph node—testicular cancer	0.000792	0.0159	CbGeAlD
Nifedipine—CALM3—female gonad—testicular cancer	0.000786	0.0158	CbGeAlD
Nifedipine—CALM2—gonad—testicular cancer	0.00076	0.0153	CbGeAlD
Nifedipine—ABCC3—testis—testicular cancer	0.000757	0.0152	CbGeAlD
Nifedipine—CALM1—gonad—testicular cancer	0.000756	0.0152	CbGeAlD
Nifedipine—CACNB2—lymph node—testicular cancer	0.000748	0.0151	CbGeAlD
Nifedipine—CYP2E1—seminal vesicle—testicular cancer	0.000733	0.0148	CbGeAlD
Nifedipine—CACNA2D1—lymph node—testicular cancer	0.000702	0.0141	CbGeAlD
Nifedipine—CALM3—testis—testicular cancer	0.000697	0.014	CbGeAlD
Nifedipine—CACNA1D—lymph node—testicular cancer	0.000654	0.0132	CbGeAlD
Nifedipine—CALM2—female gonad—testicular cancer	0.000617	0.0124	CbGeAlD
Nifedipine—CALM1—female gonad—testicular cancer	0.000614	0.0124	CbGeAlD
Nifedipine—ABCC2—testis—testicular cancer	0.000605	0.0122	CbGeAlD
Nifedipine—CACNA1C—lymph node—testicular cancer	0.000603	0.0121	CbGeAlD
Nifedipine—CYP2B6—gonad—testicular cancer	0.000565	0.0114	CbGeAlD
Nifedipine—ABCC3—lymph node—testicular cancer	0.000549	0.0111	CbGeAlD
Nifedipine—CALM2—testis—testicular cancer	0.000547	0.011	CbGeAlD
Nifedipine—CALM1—testis—testicular cancer	0.000545	0.011	CbGeAlD
Nifedipine—CALM3—lymph node—testicular cancer	0.000505	0.0102	CbGeAlD
Nifedipine—CYP1A1—female gonad—testicular cancer	0.000472	0.00951	CbGeAlD
Nifedipine—CYP3A5—female gonad—testicular cancer	0.000462	0.0093	CbGeAlD
Nifedipine—CYP2C8—testis—testicular cancer	0.000454	0.00914	CbGeAlD
Nifedipine—ABCB1—embryo—testicular cancer	0.000445	0.00895	CbGeAlD
Nifedipine—ABCC2—lymph node—testicular cancer	0.000439	0.00883	CbGeAlD
Nifedipine—ABCB1—seminal vesicle—testicular cancer	0.000418	0.00841	CbGeAlD
Nifedipine—CYP2B6—testis—testicular cancer	0.000407	0.0082	CbGeAlD
Nifedipine—CALM2—lymph node—testicular cancer	0.000397	0.00799	CbGeAlD
Nifedipine—CALM1—lymph node—testicular cancer	0.000395	0.00795	CbGeAlD
Nifedipine—CYP2E1—testis—testicular cancer	0.000382	0.00769	CbGeAlD
Nifedipine—CYP2D6—female gonad—testicular cancer	0.000341	0.00687	CbGeAlD
Nifedipine—CYP1A1—lymph node—testicular cancer	0.000304	0.00611	CbGeAlD
Nifedipine—CYP2D6—testis—testicular cancer	0.000302	0.00609	CbGeAlD
Nifedipine—ABCB1—gonad—testicular cancer	0.000302	0.00608	CbGeAlD
Nifedipine—ABCB1—female gonad—testicular cancer	0.000245	0.00494	CbGeAlD
Nifedipine—ABCB1—testis—testicular cancer	0.000218	0.00438	CbGeAlD
Nifedipine—ABCB1—lymph node—testicular cancer	0.000158	0.00318	CbGeAlD
Nifedipine—Eye disorder—Methotrexate—testicular cancer	0.000118	0.000599	CcSEcCtD
Nifedipine—Tinnitus—Methotrexate—testicular cancer	0.000118	0.000598	CcSEcCtD
Nifedipine—Hypoaesthesia—Epirubicin—testicular cancer	0.000118	0.000597	CcSEcCtD
Nifedipine—Asthenia—Cisplatin—testicular cancer	0.000118	0.000596	CcSEcCtD
Nifedipine—Pharyngitis—Epirubicin—testicular cancer	0.000118	0.000596	CcSEcCtD
Nifedipine—Cardiac disorder—Methotrexate—testicular cancer	0.000118	0.000595	CcSEcCtD
Nifedipine—Sweating—Doxorubicin—testicular cancer	0.000117	0.000593	CcSEcCtD
Nifedipine—Urinary tract disorder—Epirubicin—testicular cancer	0.000117	0.000593	CcSEcCtD
Nifedipine—Oedema peripheral—Epirubicin—testicular cancer	0.000117	0.000591	CcSEcCtD
Nifedipine—Haematuria—Doxorubicin—testicular cancer	0.000117	0.00059	CcSEcCtD
Nifedipine—Connective tissue disorder—Epirubicin—testicular cancer	0.000117	0.00059	CcSEcCtD
Nifedipine—Urethral disorder—Epirubicin—testicular cancer	0.000116	0.000588	CcSEcCtD
Nifedipine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000116	0.000585	CcSEcCtD
Nifedipine—Epistaxis—Doxorubicin—testicular cancer	0.000115	0.000583	CcSEcCtD
Nifedipine—Angiopathy—Methotrexate—testicular cancer	0.000115	0.000582	CcSEcCtD
Nifedipine—Sinusitis—Doxorubicin—testicular cancer	0.000115	0.00058	CcSEcCtD
Nifedipine—Immune system disorder—Methotrexate—testicular cancer	0.000114	0.000579	CcSEcCtD
Nifedipine—Visual impairment—Epirubicin—testicular cancer	0.000114	0.000578	CcSEcCtD
Nifedipine—Mediastinal disorder—Methotrexate—testicular cancer	0.000114	0.000578	CcSEcCtD
Nifedipine—Agranulocytosis—Doxorubicin—testicular cancer	0.000114	0.000577	CcSEcCtD
Nifedipine—Chills—Methotrexate—testicular cancer	0.000114	0.000575	CcSEcCtD
Nifedipine—Nausea—Ifosfamide—testicular cancer	0.000113	0.000572	CcSEcCtD
Nifedipine—Diarrhoea—Cisplatin—testicular cancer	0.000112	0.000568	CcSEcCtD
Nifedipine—Erythema multiforme—Epirubicin—testicular cancer	0.000112	0.000567	CcSEcCtD
Nifedipine—Alopecia—Methotrexate—testicular cancer	0.000112	0.000567	CcSEcCtD
Nifedipine—Bradycardia—Doxorubicin—testicular cancer	0.000112	0.000565	CcSEcCtD
Nifedipine—Mental disorder—Methotrexate—testicular cancer	0.000111	0.000562	CcSEcCtD
Nifedipine—Eye disorder—Epirubicin—testicular cancer	0.000111	0.000561	CcSEcCtD
Nifedipine—Hypersensitivity—Etoposide—testicular cancer	0.000111	0.00056	CcSEcCtD
Nifedipine—Tinnitus—Epirubicin—testicular cancer	0.000111	0.00056	CcSEcCtD
Nifedipine—Malnutrition—Methotrexate—testicular cancer	0.00011	0.000558	CcSEcCtD
Nifedipine—Erythema—Methotrexate—testicular cancer	0.00011	0.000558	CcSEcCtD
Nifedipine—Haemoglobin—Doxorubicin—testicular cancer	0.00011	0.000558	CcSEcCtD
Nifedipine—Flushing—Epirubicin—testicular cancer	0.00011	0.000557	CcSEcCtD
Nifedipine—Cardiac disorder—Epirubicin—testicular cancer	0.00011	0.000557	CcSEcCtD
Nifedipine—Rhinitis—Doxorubicin—testicular cancer	0.00011	0.000557	CcSEcCtD
Nifedipine—Hepatitis—Doxorubicin—testicular cancer	0.00011	0.000555	CcSEcCtD
Nifedipine—Haemorrhage—Doxorubicin—testicular cancer	0.00011	0.000555	CcSEcCtD
Nifedipine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000109	0.000553	CcSEcCtD
Nifedipine—Pharyngitis—Doxorubicin—testicular cancer	0.000109	0.000551	CcSEcCtD
Nifedipine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000108	0.000548	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—testicular cancer	0.000108	0.000547	CcSEcCtD
Nifedipine—Dysgeusia—Methotrexate—testicular cancer	0.000108	0.000547	CcSEcCtD
Nifedipine—Asthenia—Etoposide—testicular cancer	0.000108	0.000546	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000108	0.000546	CcSEcCtD
Nifedipine—Angiopathy—Epirubicin—testicular cancer	0.000108	0.000545	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—testicular cancer	0.000108	0.000544	CcSEcCtD
Nifedipine—Immune system disorder—Epirubicin—testicular cancer	0.000107	0.000542	CcSEcCtD
Nifedipine—Mediastinal disorder—Epirubicin—testicular cancer	0.000107	0.000541	CcSEcCtD
Nifedipine—Back pain—Methotrexate—testicular cancer	0.000107	0.00054	CcSEcCtD
Nifedipine—Chills—Epirubicin—testicular cancer	0.000106	0.000539	CcSEcCtD
Nifedipine—Pruritus—Etoposide—testicular cancer	0.000106	0.000538	CcSEcCtD
Nifedipine—Arrhythmia—Epirubicin—testicular cancer	0.000106	0.000536	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—testicular cancer	0.000106	0.000535	CcSEcCtD
Nifedipine—Alopecia—Epirubicin—testicular cancer	0.000105	0.00053	CcSEcCtD
Nifedipine—Vomiting—Cisplatin—testicular cancer	0.000104	0.000528	CcSEcCtD
Nifedipine—Vision blurred—Methotrexate—testicular cancer	0.000104	0.000526	CcSEcCtD
Nifedipine—Mental disorder—Epirubicin—testicular cancer	0.000104	0.000526	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—testicular cancer	0.000104	0.000525	CcSEcCtD
Nifedipine—Rash—Cisplatin—testicular cancer	0.000103	0.000524	CcSEcCtD
Nifedipine—Dermatitis—Cisplatin—testicular cancer	0.000103	0.000523	CcSEcCtD
Nifedipine—Malnutrition—Epirubicin—testicular cancer	0.000103	0.000522	CcSEcCtD
Nifedipine—Erythema—Epirubicin—testicular cancer	0.000103	0.000522	CcSEcCtD
Nifedipine—Diarrhoea—Etoposide—testicular cancer	0.000103	0.00052	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—testicular cancer	0.000103	0.000519	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—testicular cancer	0.000102	0.000518	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—testicular cancer	0.000102	0.000518	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—testicular cancer	0.000102	0.000516	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—testicular cancer	0.000102	0.000515	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—testicular cancer	0.000102	0.000515	CcSEcCtD
Nifedipine—Flatulence—Epirubicin—testicular cancer	0.000102	0.000515	CcSEcCtD
Nifedipine—Tension—Epirubicin—testicular cancer	0.000101	0.000513	CcSEcCtD
Nifedipine—Dysgeusia—Epirubicin—testicular cancer	0.000101	0.000512	CcSEcCtD
Nifedipine—Nervousness—Epirubicin—testicular cancer	0.0001	0.000507	CcSEcCtD
Nifedipine—Back pain—Epirubicin—testicular cancer	9.98e-05	0.000505	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—testicular cancer	9.95e-05	0.000504	CcSEcCtD
Nifedipine—Malaise—Methotrexate—testicular cancer	9.95e-05	0.000503	CcSEcCtD
Nifedipine—Dizziness—Etoposide—testicular cancer	9.94e-05	0.000503	CcSEcCtD
Nifedipine—Muscle spasms—Epirubicin—testicular cancer	9.92e-05	0.000502	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—testicular cancer	9.91e-05	0.000502	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—testicular cancer	9.91e-05	0.000502	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—testicular cancer	9.89e-05	0.0005	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—testicular cancer	9.87e-05	0.0005	CcSEcCtD
Nifedipine—Chills—Doxorubicin—testicular cancer	9.84e-05	0.000498	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—testicular cancer	9.8e-05	0.000496	CcSEcCtD
Nifedipine—Nausea—Cisplatin—testicular cancer	9.74e-05	0.000493	CcSEcCtD
Nifedipine—Vision blurred—Epirubicin—testicular cancer	9.73e-05	0.000492	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—testicular cancer	9.7e-05	0.000491	CcSEcCtD
Nifedipine—Cough—Methotrexate—testicular cancer	9.63e-05	0.000487	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—testicular cancer	9.61e-05	0.000487	CcSEcCtD
Nifedipine—Ill-defined disorder—Epirubicin—testicular cancer	9.58e-05	0.000485	CcSEcCtD
Nifedipine—Vomiting—Etoposide—testicular cancer	9.56e-05	0.000484	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—testicular cancer	9.55e-05	0.000483	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—testicular cancer	9.55e-05	0.000483	CcSEcCtD
Nifedipine—Anaemia—Epirubicin—testicular cancer	9.54e-05	0.000483	CcSEcCtD
Nifedipine—Agitation—Epirubicin—testicular cancer	9.49e-05	0.00048	CcSEcCtD
Nifedipine—Rash—Etoposide—testicular cancer	9.48e-05	0.00048	CcSEcCtD
Nifedipine—Dermatitis—Etoposide—testicular cancer	9.47e-05	0.000479	CcSEcCtD
Nifedipine—Headache—Etoposide—testicular cancer	9.42e-05	0.000477	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—testicular cancer	9.41e-05	0.000476	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—testicular cancer	9.39e-05	0.000475	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—testicular cancer	9.39e-05	0.000475	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—testicular cancer	9.39e-05	0.000475	CcSEcCtD
Nifedipine—Tension—Doxorubicin—testicular cancer	9.37e-05	0.000474	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—testicular cancer	9.35e-05	0.000473	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	9.33e-05	0.000472	CcSEcCtD
Nifedipine—Malaise—Epirubicin—testicular cancer	9.31e-05	0.000471	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—testicular cancer	9.28e-05	0.00047	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—testicular cancer	9.28e-05	0.00047	CcSEcCtD
Nifedipine—Vertigo—Epirubicin—testicular cancer	9.27e-05	0.000469	CcSEcCtD
Nifedipine—Syncope—Epirubicin—testicular cancer	9.26e-05	0.000469	CcSEcCtD
Nifedipine—Leukopenia—Epirubicin—testicular cancer	9.24e-05	0.000468	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—testicular cancer	9.24e-05	0.000468	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—testicular cancer	9.18e-05	0.000465	CcSEcCtD
Nifedipine—Palpitations—Epirubicin—testicular cancer	9.12e-05	0.000462	CcSEcCtD
Nifedipine—Confusional state—Methotrexate—testicular cancer	9.08e-05	0.000459	CcSEcCtD
Nifedipine—Loss of consciousness—Epirubicin—testicular cancer	9.07e-05	0.000459	CcSEcCtD
Nifedipine—Cough—Epirubicin—testicular cancer	9.01e-05	0.000456	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—testicular cancer	9e-05	0.000456	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—testicular cancer	9e-05	0.000456	CcSEcCtD
Nifedipine—Nausea—Etoposide—testicular cancer	8.93e-05	0.000452	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—testicular cancer	8.86e-05	0.000449	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—testicular cancer	8.83e-05	0.000447	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—testicular cancer	8.83e-05	0.000447	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—testicular cancer	8.81e-05	0.000446	CcSEcCtD
Nifedipine—Chest pain—Epirubicin—testicular cancer	8.79e-05	0.000445	CcSEcCtD
Nifedipine—Arthralgia—Epirubicin—testicular cancer	8.79e-05	0.000445	CcSEcCtD
Nifedipine—Myalgia—Epirubicin—testicular cancer	8.79e-05	0.000445	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—testicular cancer	8.78e-05	0.000444	CcSEcCtD
Nifedipine—Anxiety—Epirubicin—testicular cancer	8.76e-05	0.000443	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—testicular cancer	8.74e-05	0.000443	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	8.73e-05	0.000442	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—testicular cancer	8.7e-05	0.00044	CcSEcCtD
Nifedipine—Discomfort—Epirubicin—testicular cancer	8.68e-05	0.000439	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—testicular cancer	8.61e-05	0.000436	CcSEcCtD
Nifedipine—Dry mouth—Epirubicin—testicular cancer	8.59e-05	0.000435	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—testicular cancer	8.58e-05	0.000434	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—testicular cancer	8.58e-05	0.000434	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—testicular cancer	8.57e-05	0.000434	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—testicular cancer	8.55e-05	0.000433	CcSEcCtD
Nifedipine—Confusional state—Epirubicin—testicular cancer	8.49e-05	0.00043	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—testicular cancer	8.44e-05	0.000427	CcSEcCtD
Nifedipine—Oedema—Epirubicin—testicular cancer	8.42e-05	0.000426	CcSEcCtD
Nifedipine—Anaphylactic shock—Epirubicin—testicular cancer	8.42e-05	0.000426	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—testicular cancer	8.41e-05	0.000426	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—testicular cancer	8.39e-05	0.000425	CcSEcCtD
Nifedipine—Cough—Doxorubicin—testicular cancer	8.33e-05	0.000422	CcSEcCtD
Nifedipine—Shock—Epirubicin—testicular cancer	8.29e-05	0.00042	CcSEcCtD
Nifedipine—Nervous system disorder—Epirubicin—testicular cancer	8.26e-05	0.000418	CcSEcCtD
Nifedipine—Thrombocytopenia—Epirubicin—testicular cancer	8.25e-05	0.000417	CcSEcCtD
Nifedipine—Tachycardia—Epirubicin—testicular cancer	8.22e-05	0.000416	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—testicular cancer	8.2e-05	0.000415	CcSEcCtD
Nifedipine—Skin disorder—Epirubicin—testicular cancer	8.18e-05	0.000414	CcSEcCtD
Nifedipine—Hyperhidrosis—Epirubicin—testicular cancer	8.14e-05	0.000412	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—testicular cancer	8.14e-05	0.000412	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—testicular cancer	8.13e-05	0.000412	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—testicular cancer	8.13e-05	0.000412	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—testicular cancer	8.13e-05	0.000412	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—testicular cancer	8.1e-05	0.00041	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—testicular cancer	8.08e-05	0.000409	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	8.08e-05	0.000409	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—testicular cancer	8.03e-05	0.000407	CcSEcCtD
Nifedipine—Anorexia—Epirubicin—testicular cancer	8.03e-05	0.000406	CcSEcCtD
Nifedipine—Dyspnoea—Methotrexate—testicular cancer	8.03e-05	0.000406	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—testicular cancer	8e-05	0.000405	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—testicular cancer	7.95e-05	0.000403	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—testicular cancer	7.92e-05	0.000401	CcSEcCtD
Nifedipine—Hypotension—Epirubicin—testicular cancer	7.87e-05	0.000398	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—testicular cancer	7.86e-05	0.000398	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—testicular cancer	7.83e-05	0.000396	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—testicular cancer	7.8e-05	0.000395	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—testicular cancer	7.8e-05	0.000395	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—testicular cancer	7.77e-05	0.000393	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—testicular cancer	7.76e-05	0.000393	CcSEcCtD
Nifedipine—Pain—Methotrexate—testicular cancer	7.7e-05	0.00039	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Epirubicin—testicular cancer	7.68e-05	0.000388	CcSEcCtD
Nifedipine—Shock—Doxorubicin—testicular cancer	7.67e-05	0.000388	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—testicular cancer	7.64e-05	0.000387	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—testicular cancer	7.63e-05	0.000386	CcSEcCtD
Nifedipine—Insomnia—Epirubicin—testicular cancer	7.62e-05	0.000386	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—testicular cancer	7.61e-05	0.000385	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—testicular cancer	7.57e-05	0.000383	CcSEcCtD
Nifedipine—Paraesthesia—Epirubicin—testicular cancer	7.56e-05	0.000383	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—testicular cancer	7.54e-05	0.000381	CcSEcCtD
Nifedipine—Dyspnoea—Epirubicin—testicular cancer	7.51e-05	0.00038	CcSEcCtD
Nifedipine—Somnolence—Epirubicin—testicular cancer	7.49e-05	0.000379	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—testicular cancer	7.43e-05	0.000376	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—testicular cancer	7.42e-05	0.000375	CcSEcCtD
Nifedipine—Dyspepsia—Epirubicin—testicular cancer	7.42e-05	0.000375	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—testicular cancer	7.36e-05	0.000373	CcSEcCtD
Nifedipine—Decreased appetite—Epirubicin—testicular cancer	7.32e-05	0.000371	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—testicular cancer	7.28e-05	0.000369	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Epirubicin—testicular cancer	7.27e-05	0.000368	CcSEcCtD
Nifedipine—Fatigue—Epirubicin—testicular cancer	7.26e-05	0.000368	CcSEcCtD
Nifedipine—Constipation—Epirubicin—testicular cancer	7.2e-05	0.000365	CcSEcCtD
Nifedipine—Pain—Epirubicin—testicular cancer	7.2e-05	0.000365	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—testicular cancer	7.15e-05	0.000362	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—testicular cancer	7.12e-05	0.00036	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—testicular cancer	7.12e-05	0.00036	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	7.1e-05	0.000359	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—testicular cancer	7.05e-05	0.000357	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—testicular cancer	7e-05	0.000354	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—testicular cancer	6.95e-05	0.000352	CcSEcCtD
Nifedipine—Feeling abnormal—Epirubicin—testicular cancer	6.94e-05	0.000351	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—testicular cancer	6.93e-05	0.000351	CcSEcCtD
Nifedipine—Gastrointestinal pain—Epirubicin—testicular cancer	6.89e-05	0.000349	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—testicular cancer	6.86e-05	0.000347	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—testicular cancer	6.78e-05	0.000343	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—testicular cancer	6.73e-05	0.000341	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—testicular cancer	6.72e-05	0.00034	CcSEcCtD
Nifedipine—Urticaria—Epirubicin—testicular cancer	6.69e-05	0.000339	CcSEcCtD
Nifedipine—Pain—Doxorubicin—testicular cancer	6.67e-05	0.000337	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—testicular cancer	6.67e-05	0.000337	CcSEcCtD
Nifedipine—Abdominal pain—Epirubicin—testicular cancer	6.66e-05	0.000337	CcSEcCtD
Nifedipine—Body temperature increased—Epirubicin—testicular cancer	6.66e-05	0.000337	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—testicular cancer	6.63e-05	0.000336	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—testicular cancer	6.46e-05	0.000327	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—testicular cancer	6.42e-05	0.000325	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—testicular cancer	6.37e-05	0.000323	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—testicular cancer	6.37e-05	0.000322	CcSEcCtD
Nifedipine—Hypersensitivity—Epirubicin—testicular cancer	6.21e-05	0.000314	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—testicular cancer	6.19e-05	0.000313	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—testicular cancer	6.16e-05	0.000312	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—testicular cancer	6.16e-05	0.000312	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—testicular cancer	6.16e-05	0.000312	CcSEcCtD
Nifedipine—Asthenia—Epirubicin—testicular cancer	6.04e-05	0.000306	CcSEcCtD
Nifedipine—Pruritus—Epirubicin—testicular cancer	5.96e-05	0.000302	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—testicular cancer	5.95e-05	0.000301	CcSEcCtD
Nifedipine—Diarrhoea—Epirubicin—testicular cancer	5.76e-05	0.000292	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—testicular cancer	5.74e-05	0.000291	CcSEcCtD
Nifedipine—Vomiting—Methotrexate—testicular cancer	5.72e-05	0.00029	CcSEcCtD
Nifedipine—Rash—Methotrexate—testicular cancer	5.68e-05	0.000287	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—testicular cancer	5.67e-05	0.000287	CcSEcCtD
Nifedipine—Headache—Methotrexate—testicular cancer	5.64e-05	0.000285	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—testicular cancer	5.59e-05	0.000283	CcSEcCtD
Nifedipine—Dizziness—Epirubicin—testicular cancer	5.57e-05	0.000282	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—testicular cancer	5.51e-05	0.000279	CcSEcCtD
Nifedipine—Vomiting—Epirubicin—testicular cancer	5.36e-05	0.000271	CcSEcCtD
Nifedipine—Nausea—Methotrexate—testicular cancer	5.35e-05	0.000271	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—testicular cancer	5.33e-05	0.00027	CcSEcCtD
Nifedipine—Rash—Epirubicin—testicular cancer	5.31e-05	0.000269	CcSEcCtD
Nifedipine—Dermatitis—Epirubicin—testicular cancer	5.31e-05	0.000269	CcSEcCtD
Nifedipine—Headache—Epirubicin—testicular cancer	5.28e-05	0.000267	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—testicular cancer	5.15e-05	0.000261	CcSEcCtD
Nifedipine—Nausea—Epirubicin—testicular cancer	5e-05	0.000253	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—testicular cancer	4.96e-05	0.000251	CcSEcCtD
Nifedipine—Rash—Doxorubicin—testicular cancer	4.91e-05	0.000249	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—testicular cancer	4.91e-05	0.000249	CcSEcCtD
Nifedipine—Headache—Doxorubicin—testicular cancer	4.88e-05	0.000247	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—testicular cancer	4.63e-05	0.000234	CcSEcCtD
Nifedipine—CALM2—Downstream signal transduction—KITLG—testicular cancer	5.55e-06	0.00358	CbGpPWpGaD
Nifedipine—CALM1—Downstream signal transduction—KITLG—testicular cancer	5.55e-06	0.00358	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR—KITLG—testicular cancer	5.52e-06	0.00356	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR—KITLG—testicular cancer	5.52e-06	0.00356	CbGpPWpGaD
Nifedipine—CALM2—Signaling by ERBB2—KITLG—testicular cancer	5.49e-06	0.00354	CbGpPWpGaD
Nifedipine—CALM1—Signaling by ERBB2—KITLG—testicular cancer	5.49e-06	0.00354	CbGpPWpGaD
Nifedipine—CALM1—DAP12 signaling—KITLG—testicular cancer	5.46e-06	0.00353	CbGpPWpGaD
Nifedipine—CALM2—DAP12 signaling—KITLG—testicular cancer	5.46e-06	0.00353	CbGpPWpGaD
Nifedipine—CACNB2—Axon guidance—MMP2—testicular cancer	5.4e-06	0.00349	CbGpPWpGaD
Nifedipine—CALM3—DAP12 interactions—KITLG—testicular cancer	5.31e-06	0.00343	CbGpPWpGaD
Nifedipine—CALM3—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	5.31e-06	0.00343	CbGpPWpGaD
Nifedipine—CALM3—Signaling by FGFR in disease—KITLG—testicular cancer	5.31e-06	0.00343	CbGpPWpGaD
Nifedipine—CACNA1H—Developmental Biology—MMP2—testicular cancer	5.3e-06	0.00342	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR—KITLG—testicular cancer	5.27e-06	0.0034	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR in Cancer—KITLG—testicular cancer	5.22e-06	0.00337	CbGpPWpGaD
Nifedipine—CALM3—Signaling by PDGF—KITLG—testicular cancer	5.2e-06	0.00335	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR in disease—KITLG—testicular cancer	5.14e-06	0.00332	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR in disease—KITLG—testicular cancer	5.14e-06	0.00332	CbGpPWpGaD
Nifedipine—CALM2—DAP12 interactions—KITLG—testicular cancer	5.14e-06	0.00332	CbGpPWpGaD
Nifedipine—CALM1—DAP12 interactions—KITLG—testicular cancer	5.14e-06	0.00332	CbGpPWpGaD
Nifedipine—CALM1—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	5.14e-06	0.00332	CbGpPWpGaD
Nifedipine—CALM2—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	5.14e-06	0.00332	CbGpPWpGaD
Nifedipine—CACNA1D—Axon guidance—MMP2—testicular cancer	5.12e-06	0.0033	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR—KITLG—testicular cancer	5.1e-06	0.00329	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR—KITLG—testicular cancer	5.1e-06	0.00329	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR in Cancer—KITLG—testicular cancer	5.05e-06	0.00326	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR in Cancer—KITLG—testicular cancer	5.05e-06	0.00326	CbGpPWpGaD
Nifedipine—CALM2—Signaling by PDGF—KITLG—testicular cancer	5.03e-06	0.00324	CbGpPWpGaD
Nifedipine—CALM1—Signaling by PDGF—KITLG—testicular cancer	5.03e-06	0.00324	CbGpPWpGaD
Nifedipine—CALM3—B Cell Activation—KITLG—testicular cancer	4.92e-06	0.00317	CbGpPWpGaD
Nifedipine—CYP1A2—Biological oxidations—HPGDS—testicular cancer	4.89e-06	0.00316	CbGpPWpGaD
Nifedipine—CALM2—B Cell Activation—KITLG—testicular cancer	4.76e-06	0.00307	CbGpPWpGaD
Nifedipine—CALM1—B Cell Activation—KITLG—testicular cancer	4.76e-06	0.00307	CbGpPWpGaD
Nifedipine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	4.73e-06	0.00305	CbGpPWpGaD
Nifedipine—CALM3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	4.71e-06	0.00304	CbGpPWpGaD
Nifedipine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	4.58e-06	0.00295	CbGpPWpGaD
Nifedipine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	4.58e-06	0.00295	CbGpPWpGaD
Nifedipine—CALM2—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	4.55e-06	0.00294	CbGpPWpGaD
Nifedipine—CALM1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	4.55e-06	0.00294	CbGpPWpGaD
Nifedipine—CALM3—Downstream signaling of activated FGFR—FGFR3—testicular cancer	4.53e-06	0.00292	CbGpPWpGaD
Nifedipine—CACNA1S—Developmental Biology—MMP2—testicular cancer	4.5e-06	0.0029	CbGpPWpGaD
Nifedipine—CACNA1C—Axon guidance—MMP2—testicular cancer	4.5e-06	0.0029	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—INSL3—testicular cancer	4.47e-06	0.00288	CbGpPWpGaD
Nifedipine—CALM3—Signaling by WNT in cancer—H2AFZ—testicular cancer	4.4e-06	0.00284	CbGpPWpGaD
Nifedipine—CALM1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	4.39e-06	0.00283	CbGpPWpGaD
Nifedipine—CALM2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	4.39e-06	0.00283	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—INSL3—testicular cancer	4.32e-06	0.00279	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—INSL3—testicular cancer	4.32e-06	0.00279	CbGpPWpGaD
Nifedipine—CALM3—Downstream signal transduction—FGFR3—testicular cancer	4.26e-06	0.00275	CbGpPWpGaD
Nifedipine—CALM2—Signaling by WNT in cancer—H2AFZ—testicular cancer	4.25e-06	0.00274	CbGpPWpGaD
Nifedipine—CALM1—Signaling by WNT in cancer—H2AFZ—testicular cancer	4.25e-06	0.00274	CbGpPWpGaD
Nifedipine—CALM3—Signaling by FGFR—FGFR3—testicular cancer	4.24e-06	0.00274	CbGpPWpGaD
Nifedipine—CALM3—Signaling by ERBB2—FGFR3—testicular cancer	4.22e-06	0.00272	CbGpPWpGaD
Nifedipine—CALM3—DAP12 signaling—FGFR3—testicular cancer	4.2e-06	0.00271	CbGpPWpGaD
Nifedipine—CALM3—Downstream signaling of activated FGFR—KIT—testicular cancer	4.16e-06	0.00269	CbGpPWpGaD
Nifedipine—CALM2—Downstream signal transduction—FGFR3—testicular cancer	4.12e-06	0.00266	CbGpPWpGaD
Nifedipine—CALM1—Downstream signal transduction—FGFR3—testicular cancer	4.12e-06	0.00266	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR—FGFR3—testicular cancer	4.1e-06	0.00265	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR—FGFR3—testicular cancer	4.1e-06	0.00265	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	4.1e-06	0.00264	CbGpPWpGaD
Nifedipine—CALM2—Signaling by ERBB2—FGFR3—testicular cancer	4.08e-06	0.00263	CbGpPWpGaD
Nifedipine—CALM1—Signaling by ERBB2—FGFR3—testicular cancer	4.08e-06	0.00263	CbGpPWpGaD
Nifedipine—CALM2—DAP12 signaling—FGFR3—testicular cancer	4.06e-06	0.00262	CbGpPWpGaD
Nifedipine—CALM1—DAP12 signaling—FGFR3—testicular cancer	4.06e-06	0.00262	CbGpPWpGaD
Nifedipine—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	4.03e-06	0.0026	CbGpPWpGaD
Nifedipine—CALM2—Downstream signaling of activated FGFR—KIT—testicular cancer	4.03e-06	0.0026	CbGpPWpGaD
Nifedipine—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	3.95e-06	0.00255	CbGpPWpGaD
Nifedipine—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	3.95e-06	0.00255	CbGpPWpGaD
Nifedipine—CALM3—DAP12 interactions—FGFR3—testicular cancer	3.95e-06	0.00255	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR—FGFR3—testicular cancer	3.91e-06	0.00253	CbGpPWpGaD
Nifedipine—CALM3—Downstream signal transduction—KIT—testicular cancer	3.91e-06	0.00252	CbGpPWpGaD
Nifedipine—CALM3—Signaling by FGFR—KIT—testicular cancer	3.89e-06	0.00251	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	3.88e-06	0.0025	CbGpPWpGaD
Nifedipine—CALM3—Signaling by ERBB2—KIT—testicular cancer	3.87e-06	0.0025	CbGpPWpGaD
Nifedipine—CALM3—Signaling by PDGF—FGFR3—testicular cancer	3.86e-06	0.00249	CbGpPWpGaD
Nifedipine—CACNB2—Developmental Biology—MMP2—testicular cancer	3.86e-06	0.00249	CbGpPWpGaD
Nifedipine—CALM3—DAP12 signaling—KIT—testicular cancer	3.85e-06	0.00249	CbGpPWpGaD
Nifedipine—CALM2—DAP12 interactions—FGFR3—testicular cancer	3.82e-06	0.00247	CbGpPWpGaD
Nifedipine—CALM1—DAP12 interactions—FGFR3—testicular cancer	3.82e-06	0.00247	CbGpPWpGaD
Nifedipine—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	3.82e-06	0.00247	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	3.82e-06	0.00247	CbGpPWpGaD
Nifedipine—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	3.82e-06	0.00247	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	3.82e-06	0.00247	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR—FGFR3—testicular cancer	3.79e-06	0.00244	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR—FGFR3—testicular cancer	3.79e-06	0.00244	CbGpPWpGaD
Nifedipine—CALM1—Downstream signal transduction—KIT—testicular cancer	3.78e-06	0.00244	CbGpPWpGaD
Nifedipine—CALM2—Downstream signal transduction—KIT—testicular cancer	3.78e-06	0.00244	CbGpPWpGaD
Nifedipine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	3.78e-06	0.00244	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—HPGDS—testicular cancer	3.77e-06	0.00243	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR—KIT—testicular cancer	3.77e-06	0.00243	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR—KIT—testicular cancer	3.77e-06	0.00243	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	3.75e-06	0.00242	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	3.75e-06	0.00242	CbGpPWpGaD
Nifedipine—CALM1—Signaling by ERBB2—KIT—testicular cancer	3.75e-06	0.00242	CbGpPWpGaD
Nifedipine—CALM2—Signaling by ERBB2—KIT—testicular cancer	3.75e-06	0.00242	CbGpPWpGaD
Nifedipine—CALM1—Signaling by PDGF—FGFR3—testicular cancer	3.74e-06	0.00241	CbGpPWpGaD
Nifedipine—CALM2—Signaling by PDGF—FGFR3—testicular cancer	3.74e-06	0.00241	CbGpPWpGaD
Nifedipine—CALM2—DAP12 signaling—KIT—testicular cancer	3.73e-06	0.00241	CbGpPWpGaD
Nifedipine—CALM1—DAP12 signaling—KIT—testicular cancer	3.73e-06	0.00241	CbGpPWpGaD
Nifedipine—CALM3—B Cell Activation—FGFR3—testicular cancer	3.66e-06	0.00236	CbGpPWpGaD
Nifedipine—CACNA1D—Developmental Biology—MMP2—testicular cancer	3.65e-06	0.00236	CbGpPWpGaD
Nifedipine—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	3.63e-06	0.00234	CbGpPWpGaD
Nifedipine—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	3.63e-06	0.00234	CbGpPWpGaD
Nifedipine—CALM3—DAP12 interactions—KIT—testicular cancer	3.63e-06	0.00234	CbGpPWpGaD
Nifedipine—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	3.62e-06	0.00234	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—KITLG—testicular cancer	3.62e-06	0.00234	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR—KIT—testicular cancer	3.59e-06	0.00232	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—HPGDS—testicular cancer	3.57e-06	0.0023	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	3.56e-06	0.0023	CbGpPWpGaD
Nifedipine—CALM3—Signaling by PDGF—KIT—testicular cancer	3.55e-06	0.00229	CbGpPWpGaD
Nifedipine—CALM2—B Cell Activation—FGFR3—testicular cancer	3.54e-06	0.00228	CbGpPWpGaD
Nifedipine—CALM1—B Cell Activation—FGFR3—testicular cancer	3.54e-06	0.00228	CbGpPWpGaD
Nifedipine—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	3.51e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	3.51e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	3.51e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	3.51e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM2—DAP12 interactions—KIT—testicular cancer	3.51e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM1—DAP12 interactions—KIT—testicular cancer	3.51e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	3.51e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	3.51e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—KITLG—testicular cancer	3.5e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—KITLG—testicular cancer	3.5e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	3.5e-06	0.00226	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR—KIT—testicular cancer	3.48e-06	0.00224	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR—KIT—testicular cancer	3.48e-06	0.00224	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	3.45e-06	0.00222	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	3.45e-06	0.00222	CbGpPWpGaD
Nifedipine—CALM2—Signaling by PDGF—KIT—testicular cancer	3.43e-06	0.00221	CbGpPWpGaD
Nifedipine—CALM1—Signaling by PDGF—KIT—testicular cancer	3.43e-06	0.00221	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—BCL10—testicular cancer	3.42e-06	0.00221	CbGpPWpGaD
Nifedipine—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	3.38e-06	0.00218	CbGpPWpGaD
Nifedipine—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	3.38e-06	0.00218	CbGpPWpGaD
Nifedipine—CALM3—B Cell Activation—KIT—testicular cancer	3.36e-06	0.00217	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—BCL10—testicular cancer	3.31e-06	0.00214	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—BCL10—testicular cancer	3.31e-06	0.00214	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—BCL10—testicular cancer	3.29e-06	0.00212	CbGpPWpGaD
Nifedipine—CALM2—B Cell Activation—KIT—testicular cancer	3.25e-06	0.00209	CbGpPWpGaD
Nifedipine—CALM1—B Cell Activation—KIT—testicular cancer	3.25e-06	0.00209	CbGpPWpGaD
Nifedipine—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	3.21e-06	0.00207	CbGpPWpGaD
Nifedipine—CACNA1C—Developmental Biology—MMP2—testicular cancer	3.21e-06	0.00207	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—BCL10—testicular cancer	3.18e-06	0.00205	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—BCL10—testicular cancer	3.18e-06	0.00205	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—HPGDS—testicular cancer	3.14e-06	0.00202	CbGpPWpGaD
Nifedipine—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	3.11e-06	0.002	CbGpPWpGaD
Nifedipine—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	3.11e-06	0.002	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.95e-06	0.0019	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—HPGDS—testicular cancer	2.81e-06	0.00181	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—STK11—testicular cancer	2.74e-06	0.00177	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.7e-06	0.00174	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—FGFR3—testicular cancer	2.69e-06	0.00174	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—INSL3—testicular cancer	2.64e-06	0.0017	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—FGFR3—testicular cancer	2.6e-06	0.00168	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—FGFR3—testicular cancer	2.6e-06	0.00168	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—STK11—testicular cancer	2.6e-06	0.00167	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—INSL3—testicular cancer	2.55e-06	0.00165	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—INSL3—testicular cancer	2.55e-06	0.00165	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—KIT—testicular cancer	2.47e-06	0.00159	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—KIT—testicular cancer	2.39e-06	0.00154	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—KIT—testicular cancer	2.39e-06	0.00154	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—STK11—testicular cancer	2.28e-06	0.00147	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.2e-06	0.00142	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—KITLG—testicular cancer	2.07e-06	0.00133	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—STK11—testicular cancer	2.04e-06	0.00132	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—KITLG—testicular cancer	2e-06	0.00129	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—KITLG—testicular cancer	2e-06	0.00129	CbGpPWpGaD
Nifedipine—CALM3—Immune System—BCL10—testicular cancer	1.99e-06	0.00129	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—KITLG—testicular cancer	1.98e-06	0.00128	CbGpPWpGaD
Nifedipine—CALM1—Immune System—BCL10—testicular cancer	1.93e-06	0.00124	CbGpPWpGaD
Nifedipine—CALM2—Immune System—BCL10—testicular cancer	1.93e-06	0.00124	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—HPGDS—testicular cancer	1.92e-06	0.00124	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—KITLG—testicular cancer	1.92e-06	0.00124	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—KITLG—testicular cancer	1.92e-06	0.00124	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.88e-06	0.00121	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—HPGDS—testicular cancer	1.76e-06	0.00114	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—FGFR3—testicular cancer	1.53e-06	0.00099	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—FGFR3—testicular cancer	1.48e-06	0.000958	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—FGFR3—testicular cancer	1.48e-06	0.000958	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—FGFR3—testicular cancer	1.47e-06	0.000951	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—FGFR3—testicular cancer	1.43e-06	0.00092	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—FGFR3—testicular cancer	1.43e-06	0.00092	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—HPGDS—testicular cancer	1.42e-06	0.000917	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—KIT—testicular cancer	1.41e-06	0.000909	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—STK11—testicular cancer	1.4e-06	0.000901	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—HPGDS—testicular cancer	1.39e-06	0.000898	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—HPGDS—testicular cancer	1.39e-06	0.000896	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—HPGDS—testicular cancer	1.38e-06	0.000892	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—KIT—testicular cancer	1.36e-06	0.000879	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—KIT—testicular cancer	1.36e-06	0.000879	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—KIT—testicular cancer	1.35e-06	0.000873	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—HPGDS—testicular cancer	1.34e-06	0.000863	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—HPGDS—testicular cancer	1.34e-06	0.000863	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—HPGDS—testicular cancer	1.31e-06	0.000847	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—KIT—testicular cancer	1.31e-06	0.000844	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—KIT—testicular cancer	1.31e-06	0.000844	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—STK11—testicular cancer	1.28e-06	0.000826	CbGpPWpGaD
Nifedipine—CALM3—Disease—H2AFZ—testicular cancer	1.21e-06	0.000779	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—HPGDS—testicular cancer	1.2e-06	0.000776	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KITLG—testicular cancer	1.2e-06	0.000776	CbGpPWpGaD
Nifedipine—CALM2—Disease—H2AFZ—testicular cancer	1.17e-06	0.000753	CbGpPWpGaD
Nifedipine—CALM1—Disease—H2AFZ—testicular cancer	1.17e-06	0.000753	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KITLG—testicular cancer	1.16e-06	0.000751	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KITLG—testicular cancer	1.16e-06	0.000751	CbGpPWpGaD
Nifedipine—CALM3—Disease—KITLG—testicular cancer	1.11e-06	0.000716	CbGpPWpGaD
Nifedipine—CALM2—Disease—KITLG—testicular cancer	1.07e-06	0.000693	CbGpPWpGaD
Nifedipine—CALM1—Disease—KITLG—testicular cancer	1.07e-06	0.000693	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—HPGDS—testicular cancer	1.05e-06	0.000676	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—STK11—testicular cancer	1.03e-06	0.000666	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—STK11—testicular cancer	1.01e-06	0.000653	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—STK11—testicular cancer	1.01e-06	0.000651	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—STK11—testicular cancer	1.01e-06	0.000648	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—HPGDS—testicular cancer	9.88e-07	0.000637	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—HPGDS—testicular cancer	9.79e-07	0.000632	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—STK11—testicular cancer	9.72e-07	0.000627	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—STK11—testicular cancer	9.72e-07	0.000627	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—STK11—testicular cancer	9.54e-07	0.000615	CbGpPWpGaD
Nifedipine—CALM3—Immune System—FGFR3—testicular cancer	8.94e-07	0.000577	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—STK11—testicular cancer	8.74e-07	0.000564	CbGpPWpGaD
Nifedipine—CALM1—Immune System—FGFR3—testicular cancer	8.65e-07	0.000558	CbGpPWpGaD
Nifedipine—CALM2—Immune System—FGFR3—testicular cancer	8.65e-07	0.000558	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—H2AFZ—testicular cancer	8.45e-07	0.000545	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STK11—testicular cancer	8.4e-07	0.000542	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—HPGDS—testicular cancer	8.37e-07	0.00054	CbGpPWpGaD
Nifedipine—CALM3—Disease—FGFR3—testicular cancer	8.25e-07	0.000532	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KIT—testicular cancer	8.21e-07	0.000529	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—H2AFZ—testicular cancer	8.18e-07	0.000528	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—H2AFZ—testicular cancer	8.18e-07	0.000528	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STK11—testicular cancer	8.13e-07	0.000524	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STK11—testicular cancer	8.13e-07	0.000524	CbGpPWpGaD
Nifedipine—CALM2—Disease—FGFR3—testicular cancer	7.98e-07	0.000515	CbGpPWpGaD
Nifedipine—CALM1—Disease—FGFR3—testicular cancer	7.98e-07	0.000515	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KIT—testicular cancer	7.94e-07	0.000512	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KIT—testicular cancer	7.94e-07	0.000512	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KITLG—testicular cancer	7.78e-07	0.000502	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—STK11—testicular cancer	7.62e-07	0.000491	CbGpPWpGaD
Nifedipine—CALM3—Disease—KIT—testicular cancer	7.58e-07	0.000489	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KITLG—testicular cancer	7.52e-07	0.000485	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KITLG—testicular cancer	7.52e-07	0.000485	CbGpPWpGaD
Nifedipine—CALM2—Disease—KIT—testicular cancer	7.33e-07	0.000473	CbGpPWpGaD
Nifedipine—CALM1—Disease—KIT—testicular cancer	7.33e-07	0.000473	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—STK11—testicular cancer	7.18e-07	0.000463	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—STK11—testicular cancer	7.12e-07	0.000459	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HPGDS—testicular cancer	6.46e-07	0.000417	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—STK11—testicular cancer	6.08e-07	0.000392	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—FGFR3—testicular cancer	5.78e-07	0.000373	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—FGFR3—testicular cancer	5.59e-07	0.000361	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—FGFR3—testicular cancer	5.59e-07	0.000361	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KIT—testicular cancer	5.31e-07	0.000342	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KIT—testicular cancer	5.13e-07	0.000331	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KIT—testicular cancer	5.13e-07	0.000331	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—STK11—testicular cancer	4.69e-07	0.000303	CbGpPWpGaD
